Search clinical trials for: Opioid Withdrawal Syndrome

Total 44226 results

USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Recruiting

Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids

Opioid Withdrawal (Disorder)

United States
University of Pennsylvania

Recruiting

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal (UH3)

Opioid Use | Opiate Withdrawal Syndrome

United States
HELP for NOWS Consortium
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach (OPTimize NOW)

Neonatal Opiate Withdrawal Syndrome

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA)

Recruiting

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome

United States
Salem Anaesthesia Pain Clinic

Recruiting

Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

Withdrawal Syndrome

Canada
Emory University
National Institute on Drug Abuse (NIDA)

Recruiting

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 (VNS in OUD UH3)

Opioid Use Disorder | Opioid Use | Withdrawal Symptoms

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel...

Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal

United States
Johns Hopkins University

Recruiting

Evaluating Buspirone to Treat Opioid Withdrawal

Anxiety | Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
Spark Biomedical, Inc.
Medical University of South Carolina; University of Texas Southwestern Medical...

Recruiting

Neurostimulation to Improve NOWS Outcomes (SPROUT)

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome

United States
DemeRx IB, Inc.
Hammersmith Medicines Research; ERT: Clinical Trial Technology Solutions; MAC...

Recruiting

A Study of Oral Ibogaine in Opioid Withdrawal

Opiate Withdrawal Syndrome

United Kingdom
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
University of Calgary

Recruiting

Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

Chronic Pain | Drug Dependence of Morphine Type | Symptom, Withdrawal

Canada
Evon Medics LLC
National Institute on Drug Abuse (NIDA); Howard University; Family and Medical... and other collaborators

Recruiting

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder (CBOT-OUD)

Withdrawal Symptoms | Craving | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe | Negative Affectivity

United States
Tufts Medical Center

Recruiting

Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.

Neonatal Opioid Withdrawal Syndrome

United States
Massachusetts General Hospital

Recruiting

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD

Sleep Disorder | Restless Legs Syndrome | Opioid-use Disorder | Opioid Withdrawal

United States
Advancing Clinical Trials in Neonatal Opioid Withdrawal...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study (OBOE)

Neonatal Opioid Withdrawal Syndrome

United States
Tulane University

Recruiting

The Effect of Music Therapy on Newborns

Neonatal Abstinence Syndrome | Substance Withdrawal, Neonatal

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (MOMs-INO)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome | Drug Abuse in Pregnancy

United States
Meir Medical Center

Completed

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal Syndrome

Delirium in the Intensive Care Unit

Israel
Advancing Clinical Trials in Neonatal Opioid Withdrawal...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
University of Vermont
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions (MOTHER DYAD)

Opioid-use Disorder | Neonatal Abstinence Syndrome | Opioid Withdrawal | Neonatal Opioid Withdrawal Syndrome

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (MOMs-CMA)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal (RELEASE)

Opioid Withdrawal

United States
Advancing Clinical Trials in Neonatal Opioid Withdrawal...
National Institutes of Health (NIH)

Active, not recruiting

Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach ((ESC-NOW))

Neonatal Opiate Withdrawal Syndrome

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Daniel Benjamin
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)

Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions

United States, Canada, United Kingdom, Israel, Singapore
Johns Hopkins University
Dalio Foundation

Completed

Oral Cannabidiol for Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
Chiesi Farmaceutici S.p.A.

Terminated

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome (NOWSHINE)

Neonatal Opioid Withdrawal Syndrome

United States
Vanderbilt University Medical Center

Completed

Jackson Pediatric Acupressure for Opioid Tapering

Iatrogenic Withdrawal Syndrome

United States
Women and Infants Hospital of Rhode Island
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
Wilkes University

Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

COVID-19 | Iatrogenic Disease | ARDS | Withdrawal Syndrome

United States
University of Pennsylvania

Completed

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal (PGB-LOF)

Opioid Withdrawal

United States
Indiana University

Completed

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid Withdrawal

United States
Wilkes University

Completed

AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)

Iatrogenic Disease | Withdrawal Syndrome

United States
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Completed

Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal

Opioid Dependence | Acute Opioid Withdrawal Syndrome

United States
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Completed

Open-Label, Safety Study of Lofexidine (NU LEAF)

Opioid Withdrawal

United States
USWM, LLC (dba US WorldMeds)

Suspended

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal (TAPER)

Opioid Withdrawal (Disorder)

United States
Thomas Jefferson University
Chiesi Farmaceutici S.p.A.

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (B-PHORE)

Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome

United States
University of Pittsburgh
Indiana University of Pennsylvania

Completed

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

Substance Use Disorders | Benzodiazepine Dependence | Alcohol Use Disorder | Substance Abuse | Opioid-use Disorder | Cocaine Use Disorder | Alcohol Abuse | Opiate Dependence | Alcohol Withdrawal | Benzodiazepine Abuse | Cocaine Abuse | Heroin Abuse | Cocaine Withdrawal | Opiate Withdrawal Syndrome | Heroin Overdoses | Heroin...

United States
Spark Biomedical, Inc.

Completed

Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Opioid-use Disorder | Opioid Withdrawal

United States
Spark Biomedical, Inc.

Completed

Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Opioid-use Disorder | Opioid Withdrawal

United States
Marc M. Perreault

Completed

Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults (SOWA-ICU)

Substance Withdrawal Syndrome

Canada
Butler Hospital

Completed

An App to Aid in Transitioning Off Opioid Medication (BetterOFF)

Opiate Withdrawal Syndrome | Opiate Use Disorder

United States
Johns Hopkins University

Completed

Buspirone for Opioid Tapering

Opioid-Related Disorders | Pain, Chronic | Dependency (Psychology) | Opiate Withdrawal Syndrome

United States
BrightView LLC
Innovative Health Solutions

Terminated

BRIDGE Device for Treatment of Opioid Withdrawal

Pain | Craving | Opioid Withdrawal

United States
St. Petersburg Bekhterev Research Psychoneurological...

Completed

Pregabalin for Opiate Withdrawal Syndrome

Opioid Withdrawal

Russian Federation
University of Zurich

Completed

How to Treat Opiate Withdrawal in Neonates

Neonatal Abstinence Syndrome
Tufts Medical Center

Completed

Improving Outcomes in Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal

United States
Hennepin Healthcare Research Institute

Completed

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

Substance Withdrawal Syndrome

United States
Stanford University
National Institute on Drug Abuse (NIDA)

Completed

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Opioid Withdrawal | Physical Dependence

United States

Search clinical trials for: Opioid Withdrawal Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations